IFPMA Code of Practice 2019 – Introduction by Melissa Barnes, Chair of the IFPMA Ethics and Business Integrity Committee (eBIC) (Video)
About IFPMA
IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere.
ifpma.org
To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.
Related news and resources
IFPMA Note for Guidance on educational and scientific events (2026 update)
Collaborations between healthcare professionals (HCPs) and the pharmaceutical industry are essential and ensure that patients have access to the medicines they need and that healthcare professionals have up-to-date comprehensive information about the diseases they treat and the medicines they prescribe.
Read more
Groups representing patients, healthcare professionals and pharmaceutical industry author new principle on use of AI in healthcare
On 26 June 2025, six leading international organizations representing patients, physicians, pharmacists, nurses, hospitals, and the pharmaceutical industry have adopted the first joint ethical principle in the healthcare industry on the responsible use of health data and technology, including artificial intelligence.
Read more
International consensus framework for ethical collaboration in health
The International Consensus Framework for Ethical Collaboration in Health is the only global platform of its kind, routinely convening diverse health stakeholders in support of high-quality patient care. First established in 2014, the Consensus Framework was revised in 2024 to coincide with its tenth anniversary and adopted in 2025 to include a new principle, on responsible use of health data and technology. This reflects a growing importance of digital health and artificial intelligence, and a need for ethics to evolve alongside innovation.
Read more